Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Six-month outcomes of switching from aflibercept to faricimab in refractory cases of neovascular age-related macular degeneration.
Kataoka K, Itagaki K, Hashiya N, Wakugawa S, Tanaka K, Nakayama M, Yamamoto A, Mukai R, Honjyo J, Maruko I, Kawai M, Miyara Y, Terao N, Wakatsuki Y, Onoe H, Mori R, Koizumi H, Sekiryu T, Iida T, Okada AA; for Japan AMD Research Consortium (JARC). Kataoka K, et al. Among authors: wakugawa s. Graefes Arch Clin Exp Ophthalmol. 2024 Jan;262(1):43-51. doi: 10.1007/s00417-023-06222-x. Epub 2023 Sep 5. Graefes Arch Clin Exp Ophthalmol. 2024. PMID: 37668741
Brolucizumab-related intraocular inflammation in Japanese patients with age-related macular degeneration: a short-term multicenter study.
Maruko I, Okada AA, Iida T, Hasegawa T, Izumi T, Kawai M, Maruko R, Nakayama M, Yamamoto A, Koizumi H, Tamashiro T, Terao N, Wakugawa S, Mori R, Onoe H, Tanaka K, Wakatsuki Y, Itagaki K, Kasai A, Ogasawara M, Sekiryu T, Shintake H, Sugano Y; Japan AMD Research Consortium. Maruko I, et al. Among authors: wakugawa s. Graefes Arch Clin Exp Ophthalmol. 2021 Sep;259(9):2857-2859. doi: 10.1007/s00417-021-05136-w. Epub 2021 Mar 15. Graefes Arch Clin Exp Ophthalmol. 2021. PMID: 33723637 Free PMC article. No abstract available.
Subfoveal choroidal thickness after brolucizumab therapy for neovascular age-related macular degeneration: a short-term multicenter study.
Tamashiro T, Tanaka K, Itagaki K, Nakayama M, Maruko I, Wakugawa S, Terao N, Onoe H, Wakatsuki Y, Ogasawara M, Sugano Y, Yamamoto A, Kataoka K, Izumi T, Kawai M, Mori R, Sekiryu T, Okada AA, Iida T, Koizumi H; Japan AMD Research Consortium (JARC). Tamashiro T, et al. Among authors: wakugawa s. Graefes Arch Clin Exp Ophthalmol. 2022 Jun;260(6):1857-1865. doi: 10.1007/s00417-021-05517-1. Epub 2022 Jan 16. Graefes Arch Clin Exp Ophthalmol. 2022. PMID: 35034215
Short-term results for brolucizumab in treatment-naïve neovascular age-related macular degeneration: a Japanese multicenter study.
Tanaka K, Koizumi H, Tamashiro T, Itagaki K, Nakayama M, Maruko I, Wakugawa S, Terao N, Onoe H, Wakatsuki Y, Kasai A, Ogasawara M, Shintake H, Sugano Y, Yamamoto A, Kataoka K, Hasegawa T, Izumi T, Kawai M, Maruko R, Sekiryu T, Okada AA, Iida T, Mori R. Tanaka K, et al. Among authors: wakugawa s. Jpn J Ophthalmol. 2022 Jul;66(4):379-385. doi: 10.1007/s10384-022-00922-3. Epub 2022 May 21. Jpn J Ophthalmol. 2022. PMID: 35595951
Three-month outcomes of faricimab loading therapy for wet age-related macular degeneration in Japan.
Mukai R, Kataoka K, Tanaka K, Miyara Y, Maruko I, Nakayama M, Watanabe Y, Yamamoto A, Wakatsuki Y, Onoe H, Wakugawa S, Terao N, Hasegawa T, Hashiya N, Kawai M, Maruko R, Itagaki K, Honjo J, Okada AA, Mori R, Koizumi H, Iida T, Sekiryu T. Mukai R, et al. Among authors: wakugawa s. Sci Rep. 2023 May 30;13(1):8747. doi: 10.1038/s41598-023-35759-4. Sci Rep. 2023. PMID: 37253802 Free PMC article.
Scleral Thickness in Steroid-Induced Central Serous Chorioretinopathy.
Sawaguchi S, Terao N, Imanaga N, Wakugawa S, Tamashiro T, Yamauchi Y, Koizumi H. Sawaguchi S, et al. Among authors: wakugawa s. Ophthalmol Sci. 2022 Feb 8;2(2):100124. doi: 10.1016/j.xops.2022.100124. eCollection 2022 Jun. Ophthalmol Sci. 2022. PMID: 36249703 Free PMC article.
Scleral Thickness in Central Serous Chorioretinopathy.
Imanaga N, Terao N, Nakamine S, Tamashiro T, Wakugawa S, Sawaguchi K, Koizumi H. Imanaga N, et al. Among authors: wakugawa s. Ophthalmol Retina. 2021 Mar;5(3):285-291. doi: 10.1016/j.oret.2020.07.011. Epub 2020 Jul 16. Ophthalmol Retina. 2021. PMID: 32683110 Free article.
12 results